Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
Financials (USD)
Sales 2019 | 413M | Sales 2020 | 463M | Capitalization | 6.07B |
---|---|---|---|---|---|
Net income 2019 | 18M | Net income 2020 | -95M | EV / Sales 2019 * | - |
Net cash position 2019 * | - | Net cash position 2020 * | - | EV / Sales 2020 * | - |
P/E ratio 2019 * |
-
| P/E ratio 2020 * |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Srivastava Sam
CEO | Chief Executive Officer | - | - |
Nicholas Slack
PSD | President | 41 | 12-06-30 |
Ian Neilson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Baumer
BRD | Director/Board Member | 56 | 18-12-31 |
Eugene Gorbach
BRD | Director/Board Member | 47 | 11-12-31 |
Stephen McLean
BRD | Director/Board Member | 66 | 11-12-31 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- WCGC Stock